ETF Holdings Breakdown of HUMA

Stock NameHumacyte Inc
TickerHUMA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS44486Q1031

News associated with HUMA

Humacyte, Inc. (NASDAQ:HUMA) Holdings Lowered by Marshall Wace LLP
Marshall Wace LLP decreased its stake in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 90.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 54,917 shares of the company’s stock after selling 529,645 shares during the quarter. Marshall Wace LLP’s holdings in Humacyte were worth […] - 2025-05-05 08:37:01
Legal & General Group Plc Acquires 13,293 Shares of Humacyte, Inc. (NASDAQ:HUMA)
Legal & General Group Plc raised its stake in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 19.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 81,405 shares of the company’s stock after buying an additional 13,293 shares during the quarter. Legal […] - 2025-04-30 07:54:52
XTX Topco Ltd Increases Position in Humacyte, Inc. (NASDAQ:HUMA)
XTX Topco Ltd boosted its holdings in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 29.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,929 shares of the company’s stock after purchasing an additional 9,880 shares during the quarter. XTX Topco Ltd’s holdings in Humacyte […] - 2025-04-28 08:11:10
Charles Schwab Investment Management Inc. Boosts Holdings in Humacyte, Inc. (NASDAQ:HUMA)
Charles Schwab Investment Management Inc. increased its stake in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 7.5% during the 4th quarter, Holdings Channel.com reports. The fund owned 775,718 shares of the company’s stock after purchasing an additional 54,400 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Humacyte were worth $3,917,000 […] - 2025-03-27 07:13:09
Intech Investment Management LLC Has $304,000 Position in Humacyte, Inc. (NASDAQ:HUMA)
Intech Investment Management LLC grew its position in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 41.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,178 shares of the company’s stock after acquiring an additional 17,563 shares during the period. […] - 2025-03-26 08:23:10
Humacyte (NASDAQ:HUMA) Given Buy Rating at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research report report published on Friday,Benzinga reports. They currently have a $25.00 target price on the stock. Several other analysts have also recently commented on the stock. Benchmark reaffirmed a “buy” rating on shares of Humacyte in a […] - 2025-03-10 05:37:45
Short Interest in Humacyte, Inc. (NASDAQ:HUMA) Drops By 6.2%
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 24,040,000 shares, a drop of 6.2% from the January 15th total of 25,640,000 shares. Based on an average daily volume of 4,330,000 shares, the short-interest ratio is […] - 2025-02-19 08:42:38
Humacyte, Inc. (NASDAQ:HUMA) Receives $13.71 Consensus Price Target from Analysts
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) has received a consensus rating of “Buy” from the eight ratings firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the […] - 2025-02-14 08:22:52

HUMA institutional holdings

The following institutional investment holdings of HUMA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 26,505USD 32,071 -0.8%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 58,215USD 70,440
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 58,215USD 70,440 -0.8%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 214USD 259 -0.8%
Total =143,149 USD 173,210
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.